The FDA hearings on breast implants in March 2019 prompted a large number of phone calls to our office. The patients had two main questions about breast implants…BIA-ALCL (Breast Implant Associated Anaplastic Large Cell Lymphoma) and BII (Breast Implant Illness). We have addressed the BIA-ALCL issues in previous blogs on this website. Briefly stated, BIA-ALCL […]